scholarly article | Q13442814 |
P2093 | author name string | Peres MF | |
Zukerman E | |||
Alonso EO | |||
Faulhaber MH | |||
Senne Soares CA | |||
Santos BF | |||
P2860 | cites work | The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee | Q29618782 |
Chronic daily headache | Q33952713 | ||
Deconstructing migraine headache into peripheral and central sensitization | Q34134608 | ||
Cerebrospinal fluid analyses in migraine patients and controls | Q34733869 | ||
Fibromyalgia, fatigue, and headache disorders | Q35065211 | ||
Why headache treatment fails | Q35101920 | ||
Central sensitization in fibromyalgia and other musculoskeletal disorders | Q35208440 | ||
Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid | Q44380439 | ||
Platelet Glycine, Glutamate and Aspartate in Primary Headache | Q46199099 | ||
Spontaneous recurrent seizures in rats: amino acid and monoamine determination in the hippocampus | Q48210073 | ||
Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons | Q48490006 | ||
Fibromyalgia is common in patients with transformed migraine | Q48682127 | ||
Neuroexcitatory plasma amino acids are elevated in migraine | Q48893091 | ||
The impact of migraine on quality of life in the general population: the GEM study. | Q51974172 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cerebrospinal fluid | Q54196 |
migraine | Q133823 | ||
P1104 | number of pages | 5 | |
P304 | page(s) | 735-739 | |
P577 | publication date | 2004-09-01 | |
P1433 | published in | Cephalalgia | Q5063251 |
P1476 | title | Cerebrospinal fluid glutamate levels in chronic migraine | |
P478 | volume | 24 |
Q37409505 | Allodynia in migraine: frequent random association or unavoidable consequence? |
Q36853404 | Altered kynurenine pathway metabolites in serum of chronic migraine patients |
Q38121110 | Biomarkers associated with migraine and their potential role in migraine management |
Q34154494 | Blockade of glutamate release by botulinum neurotoxin type A in humans: a dermal microdialysis study. |
Q36546364 | Cerebrospinal fluid biomarkers in primary headache disorders |
Q37363477 | Chronic migraine: current pathophysiologic concepts as targets for treatment |
Q55119772 | Comparison of Pregabalin and Sodium Valproate in Migraine Prophylaxis: A Randomized Double-Blinded Study. |
Q35374174 | Dysfunctional neurotransmitter systems in fibromyalgia, their role in central stress circuitry and pharmacological actions on these systems |
Q46146404 | Effective prophylactic treatments of migraine lower plasma glutamate levels |
Q37579465 | Electroacupuncture at Acupoints Reverses Plasma Glutamate, Lipid, and LDL/VLDL in an Acute Migraine Rat Model: A (1) H NMR-Based Metabolomic Study |
Q33684257 | Elevated insular glutamate in fibromyalgia is associated with experimental pain |
Q37271327 | Excitatory neurotransmitters in brain regions in interictal migraine patients |
Q38601633 | Fibromyalgia: A Critical and Comprehensive Review |
Q37258900 | Fibromyalgia: an update and immunological aspects |
Q94460429 | From transformation to chronification of migraine: pathophysiological and clinical aspects |
Q28249721 | Future drugs for migraine |
Q50689549 | Genetic analysis of GRIA2 and GRIA4 genes in migraine. |
Q35658661 | Genotype-phenotype correlation in migraine without aura focusing on the rs1835740 variant on 8q22.1. |
Q52672731 | Glutamate and Its Receptors as Therapeutic Targets for Migraine. |
Q43358780 | Glutamate oxaloacetate transaminase: a new key in the dysregulation of glutamate in migraine patients |
Q92056807 | Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia |
Q38346851 | Headache research and medical practice in Brazil: an historical overview. |
Q33812736 | Headache-type adverse effects of NO donors: vasodilation and beyond |
Q46639229 | Increased plasma glutamate, glycine, and arginine levels in complex regional pain syndrome type 1. |
Q36405681 | Intravenous treatment of chronic daily headaches in the outpatient headache clinic |
Q34317484 | Kynurenines in the CNS: recent advances and new questions. |
Q35578143 | Large-scale mass spectrometry imaging investigation of consequences of cortical spreading depression in a transgenic mouse model of migraine. |
Q51010531 | Migraine and cognition in children: a controlled study. |
Q58867807 | Migraine and motion sickness independently contribute to visual discomfort |
Q28078828 | Molecular factors in migraine |
Q37258906 | Neuromodulators for the treatment of headache disorders and fibromyalgia |
Q92126278 | Neurotransmitter and tryptophan metabolite concentration changes in the complete Freund's adjuvant model of orofacial pain |
Q35722682 | PRRT2 Mutant Leads to Dysfunction of Glutamate Signaling |
Q37750554 | Pathogenesis of migraine: from neurotransmitters to neuromodulators and beyond |
Q38016505 | Pathogenesis of migraine: role of neuromodulators |
Q35539662 | Polymorphism of the Glutamate Transporter Protein EAAT2 and Migraine Transformation into Chronic Daily Headache |
Q51181390 | Reduced urinary glutamate levels are associated with the frequency of migraine attacks in females. |
Q47415985 | Salivary glutamate is elevated in individuals with chronic migraine. |
Q36951346 | Sensitization, glutamate, and the link between migraine and fibromyalgia |
Q36961660 | Survey of ALS-associated factors potentially promoting Ca2+ overload of motor neurons |
Q33794568 | The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat. |
Q26745558 | The Influence of Na(+), K(+)-ATPase on Glutamate Signaling in Neurodegenerative Diseases and Senescence |
Q84199783 | [Chronic cluster headache : how much does treatment cost?] |
Q53067651 | [Pain perception of adolescents with chronic functional pain : adaptation and psychometric validation of the Pain Perception Scale (SES) by Geissner]. |
Q86695252 | [Update on trigeminal autonomic cephalalgia] |
Search more.